Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.

Abstract

Diffuse intrinsic pontine glioma (DIPG) is a high-grade glioma that originates in the pons and is seen exclusively in children. Despite numerous efforts to improve treatment, DIPG remains incurable with 90% of children dying within 2 y of diagnosis, making it one of the leading causes of death in children with brain tumors. With the advent of new genomic tools, the genetic landscape of DIPG is slowly being unraveled. The most common genetic alterations include a K27M mutation in H3.3 or H3.1, which are found in up to 78% of DIPGs, whereas p53 mutations are found in up to 77%. Other recently discovered alterations include amplification of components of the receptor tyrosine kinase/Ras/phosphatidylinositol 3-kinase signaling pathway, particularly platelet-derived growth factor receptor A. Recapitulating such alterations, genetically engineered DIPG preclinical models have been developed, and DIPG xenograft models have also been established. Both models have strengths and weaknesses but can help with the prioritization of novel agents for clinical trials for children with DIPG. As we move forward, it is important that we continue to study the complex and unique biology of DIPG and develop improved preclinical models to increase our understanding of DIPG pathogenesis, allowing translation into successful therapies in the not too distant future.

• Authors: Kristin M Schroeder, Christine M Hoeman, Oren J Becher
• Journal: Pediatric research (Pediatr Res) Vol. 75 Issue 1-2 Pg. 205-9 (Jan 2014) ISSN: 1530-0447 [Electronic] United States
• PMID: 24192697 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)

Topics

• Adult
• Age Factors
• Animals
• Brain Stem Neoplasms (genetics, metabolism, mortality, pathology, therapy)
• Child
• Clinical Trials as Topic (methods)
• Disease Models, Animal
• Genetic Predisposition to Disease
• Glioma (genetics, metabolism, mortality, pathology, therapy)
• Humans
• Mutation
• Phenotype
• Signal Transduction
• Translational Research, Biomedical
• Treatment Outcome